Secretome of Hypoxia-Preconditioned Mesenchymal Stem Cells Promotes Liver Regeneration and Anti-Fibrotic Effect in Liver Fibrosis Animal Model
Pakistan Journal of Biological Sciences · 2024
DOI: 10.3923/pjbs.2024.18.26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pakistan Journal of Biological Sciences, 2024. Verfasst von Farid Amansyah und 9 weiteren Autor:innen. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Background and Objective: Liver fibrosis (LF) is a most common pathological process characterized by the activation of hepatocytes leading to the accumulation of extracellular matrix (ECM). Hypoxia precondition treated in MSCs (H-MSCs) could enhance their immunomodulatory and regeneration capability, through expressing robust anti-inflammatory cytokines and growth factors, known as H-MSCs secretome (SH-MSCs) that are critical for the improvement of liver fibrosis. However, the study regarding the efficacy and mechanism of action of SH-MSCs in ameliorating liver fibrosis is still inconclusive. In this study, the therapeutic potential and underlying mechanism for SH-MSCs in the treatment of liver fibrosis were investigated. Materials and Methods: A rat model with liver fibrosis induced by CCl 4 was created and maintained for 8 weeks. The rats received intravenous doses of SH-MSCs and secretome derived from normoxia MSCs (SN-MSCs), filtered using a tangential flow filtration (TFF) system with different molecular weight cut-off categories, both at a dosage of 0.5 mL. The ELISA assay was employed to examine the cytokines and growth factors present in both SH-MSCs and SN-MSCs. On the ninth day, the rats were euthanized and liver tissues were collected for subsequent histological examination and analysis of mRNA expression.
Results
The ELISA test revealed that SH-MSCs exhibited higher levels of VEGF, PDGF, bFGF, IL-10, TGF-β and IL-6 compared to SN-MSCs. In vivo , administration of SH-MSCs notably decreased mortality rates. It also demonstrated a reduction in liver fibrosis, collagen fiber areas, α-SMA positive staining and relative mRNA expression of TGF-β. Conversely, SN-MSCs also contributed to liver fibrosis improvement, although SH-MSCs demonstrated more favorable outcomes.
Conclusion
Current findings suggested that SH-MSCs could improve CCl 4 -induced liver fibrosis and decrease α-SMA and TGF-β expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Amansyah, F., Budu, B., Achmad, M. H., Daud, N. M. A. S., Putra, A., Massi, M. N., Bukhari, A., Hardjo, M., Parewangi, L., & Patellongi, I. (2024). Secretome of Hypoxia-Preconditioned Mesenchymal Stem Cells Promotes Liver Regeneration and Anti-Fibrotic Effect in Liver Fibrosis Animal Model. Pakistan Journal of Biological Sciences. https://doi.org/10.3923/pjbs.2024.18.26
Vancouver
Amansyah F, Budu B, Achmad MH, Daud NMAS, Putra A, Massi MN, et al. Secretome of Hypoxia-Preconditioned Mesenchymal Stem Cells Promotes Liver Regeneration and Anti-Fibrotic Effect in Liver Fibrosis Animal Model. Pakistan Journal of Biological Sciences. 2024. doi:10.3923/pjbs.2024.18.26
BibTeX
@article{Amansyah2024,
author = {Amansyah, Farid and Budu, B and Achmad, Muhammad Harun and Daud, Nu Man A S and Putra, Agung and Massi, Muhammad Nasrum and Bukhari, Agussalim and Hardjo, Marhaen and Parewangi, Luthfi and Patellongi, Ilhamjaya},
title = {Secretome of Hypoxia-Preconditioned Mesenchymal Stem Cells Promotes Liver Regeneration and Anti-Fibrotic Effect in Liver Fibrosis Animal Model},
journal = {Pakistan Journal of Biological Sciences},
year = {2024},
doi = {10.3923/pjbs.2024.18.26}
}
EUVIMED